Stock Events

Stock Events

Bioventus 

$13.88
29
-$0.10-0.68% 19:11 Today

Statistics

Day High
14.04
Day Low
13.72
52W High
15.89
52W Low
6.26
Volume
217,671
Avg. Volume
742,561
Mkt Cap
947.73M
P/E Ratio
28.98
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Mar 4
$0.61
Dec 3
$0.61
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.02
0.09
0.15
0.22
Expected EPS
0.15964
Actual EPS
N/A

Financials

4%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
568.09MRevenue
22.73MNet Income

Analyst Ratings

16.00Average Price Target
The highest estimate is 19.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BVS. It's not an investment recommendation.
NVIDIA
9
NVDA
Broadcom
7
AVGO
ExxonMobil
7
XOM
Microsoft
6
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap126.37B
Stryker Corporation is a direct competitor in the orthopedic and medical technology market, offering similar products for joint replacement and surgical solutions.
Zimmer Biomet
ZBH
Mkt Cap19.26B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, providing a range of products for joint reconstruction, similar to Bioventus' offerings.
Medtronic
MDT
Mkt Cap119.49B
Medtronic plc offers products in the areas of spinal and musculoskeletal health, directly competing with Bioventus' solutions for orthobiologics and surgical healing.
Johnson & Johnson
JNJ
Mkt Cap651.25B
Johnson & Johnson, through its DePuy Synthes division, competes in the orthopedics market, offering products that overlap with Bioventus' portfolio in joint and tissue healing.
Boston Scientific
BSX
Mkt Cap73B
Boston Scientific Corporation competes with Bioventus in the medical device sector, particularly in pain management and chronic conditions treatments.
Smith & Nephew
SNN
Mkt Cap12.25B
Smith & Nephew plc offers advanced wound management products, orthopedic reconstruction, and sports medicine, directly competing with Bioventus in these areas.
Globant.
GLOB
Mkt Cap1.71B
Globus Medical, Inc. competes in the development of musculoskeletal solutions, particularly in spine and orthopedics, similar to Bioventus' focus areas.
K2 Capital Acquisition
KTWO
Mkt Cap201.41M
K2M Group Holdings, Inc. (acquired by Stryker) was known for its innovative spine and minimally invasive solutions, competing in the same space as Bioventus.

About

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Show more...
CEO
Robert Claypoole
Employees
950
Country
United States
ISIN
US09075A1088
WKN
000A2APNA

Listings

F
DE
4B8.F
BOATS
BOATS
BVS.BOATS
XNAS
US
BVS

0 Comments

Share your thoughts

FAQ

What is Bioventus stock price today?▼
The current price of BVS is $13.88 USD — it has decreased by -0.68% in the past 24 hours. Watch Bioventus stock price performance more closely on the chart.
What is Bioventus stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Bioventus stocks are traded under the ticker BVS.
Is Bioventus stock price growing?▼
BVS stock has fallen by -3.14% compared to the previous week, the month change is a +11.49% rise, over the last year Bioventus has showed a +85.31% increase.
What is Bioventus market cap?▼
Today Bioventus has the market capitalization of 947.73M
When is the next Bioventus earnings date?▼
Bioventus is going to release the next earnings report on November 10, 2026.
What were Bioventus earnings last quarter?▼
BVS earnings for the last quarter are 0.22 USD per share, whereas the estimation was 0.22 USD resulting in a +1.72% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bioventus revenue for the last year?▼
Bioventus revenue for the last year amounts to 568.09M USD.
What is Bioventus net income for the last year?▼
BVS net income for the last year is 22.73M USD.
Does Bioventus pay dividends?▼
Yes, BVS dividends are paid en. The last dividend per share was 0.61 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Bioventus have?▼
As of August 27, 2026, the company has 950 employees.
In which sector is Bioventus located?▼
Bioventus operates in the Health & Wellness sector.
When did Bioventus complete a stock split?▼
Bioventus has not had any recent stock splits.
Where is Bioventus headquartered?▼
Bioventus is headquartered in DURHAM, United States.